GALMED PHARMACEUTICALS LTD. Debt Securities, Available-for-sale, Amortized Cost
GALMED PHARMACEUTICALS LTD. (GLMD) had Debt Securities, Available-for-sale, Amortized Cost of $7.33 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-03-31
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $7.33M.
- 2024-12-31: Debt Securities, Available-for-sale, Amortized Cost $7.60M.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost $7.98M.
- 2022-12-31: Debt Securities, Available-for-sale, Amortized Cost $12.51M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2025-12-31 | $7.33M 20-F · filed 2026-03-31 |
| 2024-12-31 | $7.60M 20-F · filed 2026-03-31 |
| 2023-12-31 | $7.98M 20-F · filed 2025-04-02 |
| 2022-12-31 | $12.51M 20-F · filed 2024-04-04 |
| 2021-12-31 | $32.10M 20-F · filed 2023-03-29 |
| 2020-12-31 | $39.86M 20-F · filed 2022-05-02 |
| 2019-12-31 | $31.59M 20-F · filed 2021-03-18 |
| 2018-12-31 | $59.97M 20-F · filed 2020-03-12 |